Management of Architectural Distortion on Mammogram
For patients with architectural distortion on mammography, the next step should be tissue sampling via core needle biopsy to rule out malignancy, as architectural distortion is the third most common presentation of breast cancer.
Understanding Architectural Distortion
Architectural distortion is defined as a localized alteration in the normal breast parenchyma with no definite mass visible. It presents as:
- Lines radiating from a central point
- Focal retraction or distortion of the edge of the parenchyma
- Trabecular distortion
Clinical Significance
- Architectural distortion represents the third most common mammographic presentation of breast cancer 1
- According to recent research, approximately 31% of architectural distortions are associated with invasive carcinoma or DCIS 2
- Malignancies associated with architectural distortion tend to be low-grade (60%), ER-positive (98%), and HER2-negative (98%) 2
Diagnostic Algorithm
1. Initial Assessment
Determine if the architectural distortion is the only finding ("single-feature AD") or if there are additional imaging features ("multi-feature AD")
- Single-feature AD: 18% risk of malignancy
- Multi-feature AD: 39% risk of malignancy 2
Classify according to BI-RADS assessment categories:
- Most architectural distortions will fall into BI-RADS 4 (suspicious abnormality) 3
- Some may be classified as BI-RADS 5 (highly suggestive of malignancy) if other suspicious features are present
2. Additional Imaging
Ultrasound: Should be performed to further characterize the area of distortion
- Ultrasound can identify lesions not visible on mammography in 63-69% of cases with pathologic findings 3
- Helps localize the lesion for biopsy
MRI: Consider if mammography and ultrasound findings are inconclusive
3. Tissue Sampling
- Core needle biopsy is the preferred method for tissue diagnosis 5
- Should be performed under imaging guidance (usually ultrasound or stereotactic)
- Provides histologic diagnosis rather than just cytology
- Allows for assessment of histological type, grade, and receptor status if malignant
Management Based on Biopsy Results
If Malignant (31% of cases):
- Proceed with appropriate breast cancer management based on type and stage
If High-Risk Lesion or Atypia:
- Surgical excision is recommended 5
If Benign with Correlating Pathology (37% of cases):
- Benign lesions that can explain architectural distortion include:
- Radial scars/complex sclerosing lesions
- Fat necrosis
- Sclerosing adenosis
- Post-surgical changes
- Follow-up imaging at 6-12 months is recommended 5
- Risk of upgrade to malignancy is low (approximately 1%) 2
If Benign without Clear Correlate for Architectural Distortion (32% of cases):
- Consider surgical excision, especially for multi-feature AD
- Risk of upgrade to malignancy is higher (approximately 9% for multi-feature AD) 2
Special Considerations
Pregnant and lactating women: Ultrasound is the first-line imaging modality, but mammography with shielding can be safely performed if architectural distortion is suspected 3
Inflammatory breast cancer: Architectural distortion may be a feature of IBC; ultrasound is important for biopsy guidance of underlying masses or architectural distortions 3
Pitfalls to Avoid
Assuming benignity without biopsy: Even with negative ultrasound, architectural distortion requires tissue sampling due to significant malignancy risk
Inadequate sampling: Ensure targeting of the architectural distortion during biopsy
Radiologic-pathologic discordance: If pathology doesn't explain the imaging finding, consider surgical excision, particularly for multi-feature AD
Missing associated calcifications: Carefully assess for microcalcifications within the area of distortion, as these may represent DCIS 6
By following this systematic approach to architectural distortion, clinicians can ensure appropriate diagnosis and management of this subtle but significant mammographic finding.